Gevo, Inc.
General ticker "GEVO" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $443.8M (TTM average)
Gevo, Inc. does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 3.7%: low 1.55$, high 1.67$
Factors to consider:
- Total employees count: 151 (+23.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Inability to achieve profitability, Inability to raise capital, Product development failure, Commercial scale operations, Acquisition/divestiture risks
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.87$, 2.53$]
- 2025-12-31 to 2026-12-31 estimated range: [0.55$, 1.71$]
Financial Metrics affecting the GEVO estimates:
- Positive: with PPE of -5.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 4.95
- Negative: negative Net income
- Positive: 2.87 < Industry operating profit margin (median), % of 5.50
- Positive: Interest expense per share per price, % of 0.96 <= 3.34
- Positive: Shareholder equity ratio, % of 83.82 > 64.23
- Positive: -14.27 < Investing cash flow per share per price, % of -12.80
Short-term GEVO quotes
Long-term GEVO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $17.20MM | $16.91MM | $163.67MM |
| Operating Expenses | $99.03MM | $107.74MM | $183.88MM |
| Operating Income | $-81.83MM | $-90.82MM | $-20.21MM |
| Non-Operating Income | $15.62MM | $12.18MM | $-12.42MM |
| Interest Expense | $2.16MM | $3.88MM | $17.56MM |
| R&D Expense | $21.37MM | $23.74MM | $16.20MM |
| Income(Loss) | $-66.22MM | $-78.64MM | $-32.63MM |
| Net Income(Loss)* | $-66.22MM | $-78.64MM | $-33.84MM |
| Stockholders Equity | $557.39MM | $489.49MM | $466.34MM |
| Inventory | $3.81MM | $4.50MM | $4.06MM |
| Assets | $650.32MM | $583.94MM | $718.93MM |
| Operating Cash Flow | $-53.72MM | $-57.38MM | $-13.40MM |
| Capital expenditure | $54.45MM | $51.09MM | $30.11MM |
| Investing Cash Flow | $114.13MM | $-51.82MM | $-226.57MM |
| Financing Cash Flow | $-0.19MM | $-7.36MM | $97.88MM |
| Earnings Per Share** | $-0.28 | $-0.34 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.